An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
N/A
Migraine is a neurological disease characterized by moderate or severe head...
Status
Completed
Location
Montefiore/Albert Einstein /ID# 252243
Start Date
2022-12-18
Trial ID
NCT05653986
Corticosteroids in Severe COVID-19(ASAP-C Study)
N/A
Administration of systemic corticosteroids for patients with severe forms o...
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
N/A
The purpose of this study is to prospectively observe the incidence rate of...